R3 Wound Care and Hyperbarics: Company Profile

Background

Mission and Vision

R3 Wound Care and Hyperbarics is dedicated to providing high-quality, outpatient wound care and hyperbaric oxygen therapy (HBOT) services. Their mission is to contribute to the healing and comfort of every patient by offering the best wound care treatments through compassionate and expert clinical care, utilizing state-of-the-art technology.

Primary Area of Focus

The company specializes in advanced treatments for chronic wounds, including diabetic ulcers, arterial insufficiency wounds, radiation wounds, and non-diabetic surgical wounds. They offer HBOT, a painless, natural medical therapy that enhances the body's natural healing process by breathing in 100% pure oxygen in a pressurized hyperbaric oxygen chamber.

Industry Significance

As a non-hospital-based provider, R3 Wound Care and Hyperbarics offers accessible and affordable wound care treatments, serving as an alternative to traditional hospital settings. Their approach has resonated with both physicians and patients, leading to the expansion of their facilities across Texas.

Key Strategic Focus

Core Objectives

• Expansion of Services: R3 aims to broaden its footprint throughout Texas and neighboring states, providing accessible and affordable wound care and HBOT services.

• Patient-Centric Care: The company focuses on delivering personalized, compassionate care to promote healing and comfort for every patient.

Specific Areas of Specialization

• Chronic Wound Management: Addressing various chronic wounds, including diabetic ulcers and radiation injuries.

• Hyperbaric Oxygen Therapy (HBOT): Utilizing HBOT to enhance the body's natural healing process.

Key Technologies Utilized

• State-of-the-Art Hyperbaric Chambers: Equipped with advanced technology to provide effective HBOT.

• Medical Gas Systems: Facilities are designed with full medical gas systems, including external housing for oxygen storage, meeting standards typically required for operating rooms.

Primary Markets Targeted

• Texas Regions: Dallas-Fort Worth, San Antonio, and Houston areas.

• Neighboring States: Plans for expansion into neighboring states to increase accessibility.

Financials and Funding

Funding History

• Acquisition by 3 Rivers Capital: In October 2020, R3 Wound Care and Hyperbarics was acquired by 3 Rivers Capital, a private equity firm focused on small businesses with EBITDA between $4-10 million.

Total Funds Raised

• Specific details regarding the total funds raised are not publicly disclosed.

Notable Investors

• 3 Rivers Capital: The private equity firm that acquired R3 in 2020.

Intended Utilization of Capital

• Expansion: Funds are likely allocated towards expanding the company's footprint and enhancing service offerings.

• Facility Development: Investments in building and equipping new clinics to meet growing demand.

Pipeline Development

Key Pipeline Candidates

• New Clinic Openings: Plans to open a new facility in Southlake, Texas, occupying 3,800 square feet, with an expected opening date around March 1, 2026.

Stages of Development

• Facility Construction: Ongoing development of new clinic spaces to accommodate increased patient volume.

Target Conditions

• Chronic Wounds: Including diabetic ulcers, arterial insufficiency wounds, and radiation injuries.

Anticipated Milestones

• Clinic Openings: Scheduled openings of new facilities to expand service coverage.

Technological Platform and Innovation

Proprietary Technologies

• Hyperbaric Chambers: State-of-the-art chambers designed to provide effective HBOT.

Significant Scientific Methods

• HBOT Protocols: Utilizing specific protocols to enhance healing in chronic wounds.

AI-Driven Capabilities

• No specific AI-driven capabilities are publicly disclosed.

Leadership Team

Executive Profiles

• Christopher Burciaga – Chief Executive Officer (CEO): Appointed in September 2024, bringing over two decades of senior-level executive experience in healthcare. Previously served as COO at Texas Institute for Neurological Disorders and held leadership roles at Baylor Institute of Rehabilitation and University of Texas Southwestern Hospital System.

• Bob Childs – Former CEO: Served as CEO prior to Christopher Burciaga, leading the company through its acquisition by 3 Rivers Capital.

• Jules Ellis – Chief Financial Officer (CFO): Oversees financial operations, ensuring fiscal responsibility and strategic financial planning.

• Christine Beard – Chief Operating Officer (COO): Manages daily operations, focusing on efficiency and quality of care.

Key Contributions

• Expansion Leadership: Guiding the company through significant growth and facility expansions.

• Operational Excellence: Implementing strategies to enhance operational efficiency and patient care quality.

Competitor Profile

Market Insights and Dynamics

• Market Size: The U.S. wound care centers market was valued at $13.5 billion in 2021 and is projected to reach $18.1 billion by 2028.

• Growth Potential: Increasing prevalence of chronic wounds and advancements in wound care treatments contribute to market growth.

Competitor Analysis

• Nirvana Hyperbaric Institute: Offers hyperbaric oxygen therapy services.

• Harch HBOT: Provides hyperbaric oxygen therapy with a focus on neurological conditions.

• Aalto Hyperbaric Medical Group: Specializes in hyperbaric oxygen therapy for various medical conditions.

Strategic Collaborations and Partnerships

• 3 Rivers Capital: The acquisition by 3 Rivers Capital in 2020 provided resources for expansion and operational improvements.

Operational Insights

• Competitive Advantages: Non-hospital-based clinics offering accessible and affordable wound care and HBOT services.

• Differentiators: State-of-the-art equipment, skilled personnel, and a warm, welcoming treatment environment.

Strategic Opportunities and Future Directions

Strategic Roadmap

• Facility Expansion: Opening new clinics in strategic locations to increase service coverage.

• Service Enhancement: Continuing to improve and expand treatment offerings to meet patient needs.

Future Business Directions

• Regional Growth: Expanding presence in Texas and neighboring states to serve a broader patient base.

• Technological Integration: Incorporating advanced technologies to enhance treatment efficacy and patient experience.

Opportunities for Expansion

• New Markets: Identifying underserved regions for potential clinic openings.

• Partnerships: Exploring collaborations with healthcare providers to expand service offerings.

Contact Information

• Website: r3healing.com

• Social Media:

• Facebook: R3 Wound Care and Hyperbarics

• Instagram: @r3healing

• LinkedIn: R3 Wound Care and Hyperbarics